Literature DB >> 2457649

Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.

T R Doel1, C Gale, G Brooke, R DiMarchi.   

Abstract

Foot-and-mouth disease virus challenge experiments in guinea-pigs and immunoassays with a range of peptides equivalent to either or both of the sequences 141 to 158 and 200 to 213 of VP1 showed the most effective structure, in terms of protection, to be one in which both 'sites' were present with a minimum of additional amino acids. An 80 residue peptide comprising amino acids 134 to 213 was considerably less effective than 40 or 45 residue peptides. The major site for the induction of protection was deduced to be in the region 141 to 158. Thus, protection with the 40 or 45 residue peptide did not appear to be due to the presence of antibody directed solely to the 200 to 213 sequence. Finally, induction of antibody to the latter site appeared to be dependent on both the size of the peptide and the disposition of 'sites' within it.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457649     DOI: 10.1099/0022-1317-69-9-2403

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies.

Authors:  J N Flynn; G D Harkiss; T Doel; R DiMarchi
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

2.  Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.

Authors:  T R Doel; C Gale; C M Do Amaral; G Mulcahy; R Dimarchi
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  MHC class II restricted recognition of FMDV peptides by bovine T cells.

Authors:  E J Glass; R A Oliver; T Collen; T R Doel; R Dimarchi; R L Spooner
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

4.  Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.

Authors:  S Kit; M Kit; R D DiMarchi; S P Little; C Gale
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 5.  Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

6.  Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide.

Authors:  T R Doel; C M Doel; R F Staple; R DiMarchi
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Modification of foot-and-mouth disease virus O1 Caseros after serial passages in the presence of antiviral polyclonal sera.

Authors:  E R Rojas; E Carrillo; M Schiappacassi; R Campos
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

Authors:  M J van Lierop; K van Maanen; R H Meloen; V P Rutten; M A de Jong; E J Hensen
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

Review 9.  Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health.

Authors:  Mar Forner; Rodrigo Cañas-Arranz; Sira Defaus; Patricia de León; Miguel Rodríguez-Pulido; Llilianne Ganges; Esther Blanco; Francisco Sobrino; David Andreu
Journal:  Vaccines (Basel)       Date:  2021-05-08

Review 10.  Strategies for mapping and imitating viral B-cell epitopes.

Authors:  J Cason
Journal:  J Virol Methods       Date:  1994-09       Impact factor: 2.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.